These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 25757289
21. Improved oral bioavailability of 20(R)-25-methoxyl-dammarane-3β, 12β, 20-triol using nanoemulsion based on phospholipid complex: design, characterization, and in vivo pharmacokinetics in rats. Zhang X, Zhang Y, Guo S, Bai F, Wu T, Zhao Y. Drug Des Devel Ther; 2016; 10():3707-3716. PubMed ID: 27877020 [Abstract] [Full Text] [Related]
22. Phospholipid complex as an approach for bioavailability enhancement of echinacoside. Li F, Yang X, Yang Y, Li P, Yang Z, Zhang C. Drug Dev Ind Pharm; 2015; 41(11):1777-84. PubMed ID: 25686726 [Abstract] [Full Text] [Related]
25. Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo. Yue PF, Yuan HL, Xie H, Xiao XH, Yang M, Liao MX, Zhu WF, Cai PL. Drug Dev Ind Pharm; 2008 Jul; 34(7):708-18. PubMed ID: 18612911 [Abstract] [Full Text] [Related]
27. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM, Elkheshen SA, Ghorab MM. Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [Abstract] [Full Text] [Related]
28. Development of liquiritigenin-phospholipid complex with the enhanced oral bioavailability. Shi CC, Qin KM, Xu K, Chen A, Cai T, Cai BC. Chin J Nat Med; 2020 Dec; 18(12):916-921. PubMed ID: 33357722 [Abstract] [Full Text] [Related]
29. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis. Semalty A. Expert Opin Drug Deliv; 2014 Aug; 11(8):1255-72. PubMed ID: 24909802 [Abstract] [Full Text] [Related]
30. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers. Zhao YQ, Wang LP, Ma C, Zhao K, Liu Y, Feng NP. Int J Nanomedicine; 2013 Aug; 8():4169-81. PubMed ID: 24204145 [Abstract] [Full Text] [Related]
31. Development and physicochemical evaluation of pharmacosomes of diclofenac. Semalty A, Semalty M, Singh D, Rawat MS. Acta Pharm; 2009 Sep; 59(3):335-44. PubMed ID: 19819829 [Abstract] [Full Text] [Related]
32. Rutin-phospholipid complex: an innovative technique in novel drug delivery system- NDDS. Singh D, Rawat MS, Semalty A, Semalty M. Curr Drug Deliv; 2012 May; 9(3):305-14. PubMed ID: 22283645 [Abstract] [Full Text] [Related]
34. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Wu TH, Yen FL, Lin LT, Tsai TR, Lin CC, Cham TM. Int J Pharm; 2008 Jan 04; 346(1-2):160-8. PubMed ID: 17689897 [Abstract] [Full Text] [Related]
35. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Yue PF, Yuan HL, Li XY, Yang M, Zhu WF. Int J Pharm; 2010 Mar 15; 387(1-2):139-46. PubMed ID: 20005937 [Abstract] [Full Text] [Related]
38. Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats. Mangrulkar S, Shah P, Navnage S, Mazumdar P, Chaple D. AAPS PharmSciTech; 2021 Jan 06; 22(1):28. PubMed ID: 33404939 [Abstract] [Full Text] [Related]
39. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique. Zu Y, Wu W, Zhao X, Li Y, Wang W, Zhong C, Zhang Y, Zhao X. Int J Pharm; 2014 Aug 25; 471(1-2):366-76. PubMed ID: 24882039 [Abstract] [Full Text] [Related]
40. Luteolin-phospholipid complex: preparation, characterization and biological evaluation. Khan J, Alexander A, Ajazuddin, Saraf S, Saraf S. J Pharm Pharmacol; 2014 Oct 25; 66(10):1451-62. PubMed ID: 24934881 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]